Učitavanje...
WEScover: selection between clinical whole exome sequencing and gene panel testing
BACKGROUND: Whole exome sequencing (WES) is widely adopted in clinical and research settings; however, one of the practical concerns is the potential false negatives due to incomplete breadth and depth of coverage for several exons in clinically implicated genes. In some cases, a targeted gene panel...
Spremljeno u:
| Izdano u: | BMC Bioinformatics |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8139020/ https://ncbi.nlm.nih.gov/pubmed/34016036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12859-021-04178-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|